$MRK News Biotechs continue to pay off 10:27 a.m
Post# of 94145
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck & Co Inc (MRK): Today's Featured Drugs Winner 5:00 p.m. Dec. 20, 2013 - TheStreet.com
AsiaInfo And Simcere Bow Out From New York 2:14 p.m. Dec. 20, 2013 - Seeking Alpha
5 Stocks Moving The Drugs Industry Upward 12:02 p.m. Dec. 20, 2013 - TheStreet.com
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Merck Launches Weight-Management-Interventions Business 10:06 a.m. Dec. 20, 2013 - WSJ.com
What To Buy: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Dec. 20, 2013 - TheStreet.com
'Dogs of the Dow' Strategy Should Be Muzzled 6:42 p.m. Dec. 19, 2013 - Barrons.com
Bristol-Myers Doubles Down on Cancer Focus 3:14 p.m. Dec. 19, 2013 - Barrons.com
The Battle Against Alzheimer's: Can An Investment In The Industry Prove Lucrative? 2:27 p.m. Dec. 19, 2013 - Seeking Alpha
French authority alleges anti-competitive practices in opioid addiction market 2:21 p.m. Dec. 19, 2013 - Seeking Alpha
Merck-Glaxo Partner for Oncology Treatment - Analyst Blog 1:20 p.m. Dec. 19, 2013 - Zacks.com
Stock Market News for December 19, 2013 - Market News 10:06 a.m. Dec. 19, 2013 - Zacks.com
Anacor Pharmaceuticals Is Not for Everyone 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Sanofi Pipeline Doesn't Support Price 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Jim Cramer's Top Stock Picks: MRK AMAT CIEN XLNX GIS 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Cramer's Mad Money - Thank You, Ben Bernanke (12/18/13) 5:46 a.m. Dec. 19, 2013 - Seeking Alpha
11 Stocks With Buybacks That Top $166 BILLION 12:16 a.m. Dec. 19, 2013 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Fed Tapers? So What? 8:26 p.m. Dec. 18, 2013 - TheStreet.com
Merck Vs. Bristol In PD-1 Cancer Drug Race 6:48 p.m. Dec. 18, 2013 - Seeking Alpha
Top Five Guru-Held Health Care Stocks 4:42 p.m. Dec. 18, 2013 - GuruFocus.com
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Dec. 20, 2013 - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet 8:22 a.m. Dec. 10, 2013 - GlobeNewswire
Merck Advances Development Program for Investigational Alzheimer's Disease Therapy, MK-8931 7:00 a.m. Dec. 10, 2013 - BusinessWire
Exostar-Powered Identity & Access Management Platform Named North America Health Care Project of the Year 9:09 a.m. Dec. 5, 2013 - BusinessWire